ILTS Consensus Conference

NAFLD/NASH: From medical treatment to liver transplantation

 

Thursday, February 15^th, 2018 at:

San Servolo Residential and Study Centre

Isola di San Servolo n. 1 – 30124 Venice, Italy

Phone: +39 041 276 5001

Fax: +39 041 276 5402

 

The Conference will convene key opinion leaders and experts, primarily hepatologists, to focus on epidemiology and prevention of NASH, medical treatment of NASH (standard of care and new potential drugs), management of end stage liver disease and cirrhosis complications, liver transplantation for NASH, immunosuppression management strategies and best practices in cases with NASH recurrence or de novo occurrence after transplant. The new scenario in hepatology due to the efficacy and safety of new anti-HCV therapy before and after liver transplantation will be also considered.

2 introductory Lectures will consider fundamental questions:

• Why NASH? Because HCV is disappearing?
• Are we also eliminating HCV in special populations?

6 lectures will go on to address:

• Epidemiology and prevention,
• Medical treatment: lifestyle changes and pharmacological therapy,
• Risk of hepatocellular carcinoma: surveillance and management,
• End stage liver disease and liver transplantation,
• Management of recurrent and de novo NAFLD/NASH after liver transplantation,
• Pediatric population.

Exchange ideas in a friendly, stimulating environment.

---

---

REGISTER NOW TO SECURE YOUR PLACE!

Please register online by 12 February 2018, 23:59 CET (GMT+2).

Should you require further assistance please don’t hesitate to contact the ILTS Registration Department:

ilts-consensusregistration@kit-group.org

Hotline: +49 30 24603 410

---

BOOK YOUR HOTEL NOW!

You can now book a room at the San Servolo by filling out the accommodation agreement and sending it to: reception@servizimetropolitani.ve.it.

Reservation hotline: + 39 041 2765001

---

DOWNLOAD THE PROGRAM BROCHURE HERE.

---

CONTINUING MEDICAL EDUCATION (CME) CREDITS

The ILTS Consensus Conference – NAFLD/NASH: From Medical Treatment to Liver Transplantation, Venice, Italy, 15/02/2018 – 15/02/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME^®) with 8 European CME credits (ECMEC^®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME^® credits to an equivalent number of AMA PRA Category 1 Credits^TM. Information on the process to convert EACCME^® credit to AMA credit can befound at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME^® for ECMEC^®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

---

CERTIFICATE OF ATTENDANCE

A Certificate of Attendance will be available electronically after the Conference. Delegates will be required to complete a survey prior to receiving the Certificate.

---

The NAFLD/NASH Conference is now compliant with the MedTech Europe Code of Ethical Business Practice.
www.ethicalmedtech.eu

After rigorous selection, K.I.T. Group GmbH is among the first organisations to earn the Medtech Ethical Charter. This is the official certification of those PCOs that demonstrate understanding and commitment to the new regulations. (https://www.ethicalmedtech.eu/ethical-charter/chartered-organisations/).

Working with K.I.T. Group GmbH, an officially licensed Medtech Trusted Partner, will offer very real advantages to Medtech member companies, medical societies, conference venues and hotels. Read more here.

---

The official Agency for Italian delegates and industry:

Barbara Mantegazza
Aria di Viaggi Srl – Congress and Fair Department
Via Matteo Bandello, 1 – 20123 Milano
P.I. 02818040152   –   IATA 38220346
Tel. +39 02.4818691
www.ariadiviaggi.it
barbara.mantegazza@ariadiviaggi.it

---

This program has been supported by Gilead Sciences, Inc through an unrestricted educational grant.

---

ILTS acknowledges the generous support of Novartis.

Event Date

February 15, 2018

Venue

Facebook

Twitter

LinkedIn